Otkrivanje i molekularna karakterizacija psećeg adenovirusa tipa 2 (CAV-2) kod pasa sa simptomima dišnog sustava držanih u skloništima u Turskoj by Mehmet Ozkan Timurkan et al.
.467ISSN 0372-5480Printed in Croatia
VETERINARSKI ARHIV 88 (4), 467-479, 2018
Detection and molecular characterization of canine adenovirus  
type 2 (CAV-2) in dogs with respiratory tract symptoms in  
shelters in Turkey
Mehmet Ozkan Timurkan1*, Hakan Aydin1, and Feray Alkan2
1Department of Virology, Faculty of Veterinary Medicine, Atatürk University, Erzurum,Turkey 
2Department of Virology, Faculty of Veterinary Medicine, Ankara University, Ankara,Turkey
________________________________________________________________________________________
TIMURKAN, M. O., H. AYDIN, F. ALKAN: Detection and molecular 
characterization of canine adenovirus type 2 (CAV-2) in dogs with respiratory tract 
symptoms in shelters in Turkey. Vet. arhiv 88, 467-479, 2018.
ABSTRACT
Canine adenoviruses are agents responsible for two different infections in Canidae. While canine adenovirus 
type 1 (CAV-1) causes contagious hepatitis (HCC) in dogs, canine adenovirus type 2 (CAV-2) is responsible 
for infectious laryngotracheitis (ILT). CAV-2, especially in the respiratory tract, leads to an infection that can 
result in death in young and cohabitant animals. In public housing such as shelters, in addition to opportunistic 
infections, a disorder defined as canine infectious respiratory disease (CIRD) may also occur frequently. In this 
study, 155 nasal swabs were collected from dogs in two shelters where cases of respiratory system infections 
were closely monitored. These samples were tested for CAV-2 using polymerase chain reaction (PCR) with 
primers designed for the CAV E3 (Early) gene. Positive amplicons were subjected to DNA sequencing. CAV-2 
nucleic acids were present in 2.5% (4/155) of the test samples. The phylogenetic assessment of the amplicon 
sequences revealed a 97.7%-98.9% similarity in the local viruses. The partial sequence analyses of the E3 
gene of CAV-2 showed that Turkish and Chinese strains have differences in 9 amino acids. These differences 
redounded on phylogenetic analyses, and the virus which was considered as a single group, is now subdivided 
into two subgroups. One subgroup comprises American-European isolates and the other one consists of Turkish 
and Chinese isolates, so this subdivision can be classified into at least two subgroups, designated China-Turkey 
and America-Europe. To our knowledge, this is the first study that has examined the possible role of CAV-2 in 
respiratory system infections in dogs in Turkey, to provide novel and updated information regarding CAV-2.
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Introduction 
Dog adenoviruses, canine adenovirus type 1 (CAV-1) and canine adenovirus type 
2 (CAV-2), are double-stranded deoxyribonucleic acid (DNA) icosahedral viruses 
belonging to the genus Mastadenovirus, of the family Adenoviridae (DUARTE et al., 
2014; WALKER et al., 2016). These viruses are genetically and antigenically related. 
CAV-1 targets the digestive tract tissue, and causes hepatitis contagiousa canis infection by 
damaging the liver. CAV-2 targets lung tissue where it causes infectious laryngotracheitis 
(HU et al., 2001).
CAV-2 has an affinity for the epithelium of the upper airway, the nasal cavity, and 
especially the throat, larynx, and trachea tissue. However, one study reportedly found 
it in the intestinal system (MACARTNEY et al., 1988), while another found that it had 
crossed the blood-brain barrier and reached the brain (BENETKA et al., 2006). This virus 
was first detected in dogs in a Canadian shelter in 1961 that had symptoms of upper 
respiratory tract infection (DITCHFIELD et al., 1962). In subsequent years, the presence 
of CAV-2 was reported in many countries such as Italy, Brazil, and India (BALBONI et 
al., 2013; PARTHIBAN et al., 2009; SILVA et al., 2014) and was also detected in Turkey, 
based on serological data alone (BULUT et al., 2013; CAN SAHNA and ASLAN, 2015).
Different methods can be used to diagnose adenoviral infections. Although various 
methods, such as virus isolation, haemaglutination, and neutralization, can be utilised for 
the diagnosis of adenoviruses, factors such as time, labour, and the systems affected by 
the infections (HU et al., 2001) have recently increased the preference for polymerase 
chain reaction (PCR)-based methods (SILVA et al., 2014; BOOMKENS et al., 2005; 
DECARO et al., 2007). The CAV-2 genome consists of gene regions that encode various 
proteins with specific functions. The most important ones are E1A, E1B (19K and 55K), 
E3, E4, pIVa2, pIIIa, pVI, pVII, pVIII, Pol, pTP, and DBP. E3 encodes several proteins 
and is the only genome region that encodes the membrane proteins that modulate the host 
response to infection (BURGERT and BLUSCH, 2000; LICHTENSTEIN et al., 2004). 
In this study, swab samples collected from dogs in shelters were tested using PCR, 
targeting the E3 gene-region to obtain information about the possible role of CAV-2 in 
respiratory system infections, and molecular characterization of local CAV-2 strains.
Materials and methods
Samples. In this study, a total of 155 nasal swabs were collected from 155 dogs 
belonging to 2 shelters. Dogs from both the shelters were found to have severe clinical 
signs of respiratory system infection. The samples were collected from animals that 
exhibited clinical signs, such as cough and nasal discharge. 
The nasal swabs were resuspended in 1 mL sterile phosphate buffer solution (PBS) 
and stored at -20 °C until the time the nucleic acid isolation was to be performed. Materials 
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were also tested for canine respiratory coronavirus, canine influenza virus, and distemper 
virus, possible aetiological agents of respiratory system infections in dogs.




Number of dogs 






n (%) Accession number (Gen Bank)
I 350 200 50 1 (2.0) Turkey/CAV2/B-U-50, KY775393




Total 155 4 (2.5) 
Extraction and Polymerase Chain Reaction (PCR). Nucleic Acid Extraction Kits 
(Cat No:GF-RD-100, Vivantis, Malaysia) were used for viral nucleic acid extraction 
from the swab supernatants. Extraction was carried out according to the manufacturer’s 
instructions. Primers and methods suitable for both CAV-1 and CAV-2 were used for 
the PCR, as recommended by HU et al., (2001) and CHATURVEDI et al. (2008). 
Consequently, the formation of PCR products in the expected sizes (508 bp and 1030 bp 
for CAV-1 and CAV-2, respectively) was analysed using DNA gel electrophoresis.
Sequencing and Phylogenetic Analyses. DNA sequencing of the amplicons of expected 
size (1030 bp) for CAV-2 was conducted via service procurement (Pendik Veterinary 
Control Institute, Istanbul, Turkey). The raw sequencing data were aligned using BioEdit 
version 7.0.5 (HALL, 1999) with the Clustal W algorithm. The phylogenetic map of the 
aligned sequences was established using MEGA version 6.0 (TAMURA et al., 2013) (Fig. 
2). Nucleotide sequence accession numbers, the partial genome sequences of CAV-2 were 
obtained from Gen Bank under the accession nos.; U77082 (Toronto), KU725673 (SV521), 
KU315335 (1.18), KU315336 (3.55), KU725672 (SV435), KU315333 (1.6), KU725674 
(SV675), JX416842 (113-3f-c04), KF676978 (60-2011-OFS), JX416841 (113-3F-c01), 
GQ915311 (HB1), EF090910 (India-CAV1), KU755720 (010515), KU755729 (16606), 
KT853097 (13-0067), M60937 (Gloxo-Vaccine), JN418926 (M1), NC002513 (BoAdV2), 
GU226970 (BatAdV-TJM), and JN252129 (BatAdV2-PPV1). This molecular study was 
approved by the Ethics Sub-Committee of the Ataturk University, Faculty of Veterinary 
Medicine (date/protocol number: 16.02.2017/2017-008) in Erzurum, Turkey.
Results
The PCR results for CAV-2, based on the E3 gene from the nasal swab samples that 
included CAV-2, revealed DNA products of the expected sizes (1030 bp) (Fig. 1). All 
samples were negative for CAV-1 and the other tested agents.
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According to the PCR and sequencing analyses results, CAV-2 nucleic acids were 
detected in 4 (2.5%) of the 155 tested swab samples. The positivity rates of the samples 
obtained from the shelters were determined as 2.0% and 2.8% (Table 1). The partial 
nucleotide sequences of the CAV-2 E3 genes in our samples were deposited in The Gen 
Bank (Table 1). The percentages of nucleic acid identified in the sequences of our CAV-2 
E3 genes were compared and the data are shown in Table 2.
In the phylogenetic analyses of the results obtained from the sequencing reactions, 
CAV-2, regarded as a single group in previous studies, was found to constitute 2 
different clusters (subgroups) when compared to the data obtained from the Gene Bank. 
Chinese and Turkish strains detected in this study belonged to the same subgroup. 
Moreover, when the nucleotide similarities of the strains were examined (Table 2), it 
was determined that the strains obtained in this study were 97.7%-98.9% similar to each 
other and 84.2%-99.7% similar to the reference strains.
The observations made during the examination of the 792 nucleotide sequence 
(almost 256 amino acids) in the partial E3 gene at the level of amino acids in different 
situations were noted (Fig. 3). Due to the genetic proximity of Chinese and Turkish 
isolates, the Chinese isolate (Accession number: GQ915311, HB1) was taken as the 
reference isolate, in phylogenetic analyses and amino acid analyses We observed the 
consistent appearance of the amino acid change at positions 126 (A→T), 136 (M→K), 
138 (N→D), 172 (T→V), 186 (E→D), 216 (V→M), 222 (N→D), 227 (V→I), and 
254 (S→P) which are predominant mutations in CAV-2 in the Italian, Brazilian, and 
American strains. However, although it was in the same subgroup of Chinese and 
Turkish strains, amino acid changes were observed at the following seven amino acid 
positions: 15 (P→D-N), 97 (W→L), 152 (K→N), 187 (D→N), 184 (I→T), 221 (P→L), 
and 250 (N→T). 
Fig. 1. PCR for canine adenovirus partial E3 gene. M: Marker (100-3000 bp, Thermo Fisher, 
Germany), NC: Negative control (Nuclease-Free Water), PC: Positive control of Canine 
adenovirus type 2, S: Positive Sample (Turkey-B-U-50).
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Fig. 2. Phylogenetic tree based on a 792 nucleotide sequence of 20 strains of adenoviruses 
(CAV-1, CAV-2, EqAdV1, BoAdV2, and BatAdV) generated by using the maximum likelihood 
algorithm, test of phylogeny is the bootstrap method with 1000 replicates, using the MEGA 6.0 
software program. Equine, Bovine and Bat adenoviruses were used as an out group. The round 
symbols (•) indicate Turkish strains. The scale bar indicates nucleotide substitutions per site.
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Fig. 3. Alignment of the deduced amino acid sequences of the partial-length E3 gene (256 amino 
acids) amplified using PCR from the clinical samples. The accession numbers of the sequences 
are described in the “Material and methods” section. Amino acid changes are shown in the 
rectangular box.
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Discussion and conclusion 
Animal care conditions and length of stay in shelters are governed by legislation in 
Turkey. These shelters are founded by government or civil organisations, and primary care 
for newly arriving animals is performed within these shelters, such as initial examination 
and vaccination. However, there is risk of severe respiratory and alimentary infections 
for reasons such as reactivation of latent viruses and the inability to quarantine incoming 
animals due to limited space and caring for more than one species (especially cats and 
dogs) in close proximity. Also, similar to dogs living in shelters, it is known that there is 
a risk of infections for dogs with owners due to their exposure to several factors during 
their daily walks. These infections often involve the digestive or respiratory system. The 
development of canine infectious respiratory disease (CIRD), previously known as Kennel 
Cough, caused by viral agents such as CAV-2, parainfluenza virus, canine respiratory 
coronavirus, and canine herpes virus, as well as bacterial agents such as Bordotella spp., 
Mycoplasma spp., and Streptococcus spp. or often with the participation of a few of them 
(BUONAVOGLIA and MARTELLA, 2007; DECARO et al., 2016; LAVAN and KNESL, 
2015).
Although CAV-1 and CAV-2 are associated with infections involving different 
clinical manifestations, they are antigenically related. Therefore, some enzyme-linked 
immunosorbent assay (ELISA)-based serologic tests detect antibodies to both these 
agents. In fact, some reports on CAV in Turkey (CAN SAHNA and ASLAN, 2015; 
BULUT et al., 2013) have reported information on CAV seropositivity. However, to the 
best of our knowledge, no studies have reported CAV-2 seroprevalence, virus isolation, 
or molecular epidemiology.
In this study, among all the dogs with respiratory system infection, 2% and 2.8% of 
them in shelters 1 and 2, respectively, showed CAV-2 positivity. SCHULZ et al. (2014) 
have reported that in addition to CAV-2, canine parainfluenza virus, canine influenza 
virus, canine respiratory coronavirus, as well as B. bronchiseptica were detected in 
varying rates among the shelter and the owned dogs, with or without acute respiratory 
system infection. Further, the presence of B. bronchiseptica was significantly higher 
in dogs with clinical respiratory infection than in the healthy looking dogs (45.6% and 
78.7%, respectively); there was a high prevalence of multiple infections. In this study, 
we did not collect data pertaining to the presence of viruses and bacterial agents, other 
than the distemper virus, canine respiratory coronavirus, and canine influenza virus. 
Therefore, it was not possible to make a definitive assessment regarding the individual 
or combined effect of CAV-2 or some other factors on the clinical status of the shelter 
dogs. However, we believe that CAV-2 played an individual or contributory role in the 
development of clinical disorders in some of the dogs in these sheltering units. However, 
detailed epidemiological analyses were not possible in the absence of the dogs’ individual 
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data regarding age, prior possession, vaccination information, and time of admission to 
the shelter.
Studies on CAV-2 are limited in the literature. Different clinical manifestations and 
different species have been reported in previous studies (DECARO et al., 2016; SILVA 
et al., 2014). In a study conducted by WHETSTONE (1988) in the United States of 
America (USA), monoclonal antibodies were used to distinguish the CAV types, where 
immunofluorescence and RFLP were applied comparatively. DECARO et al., (2016) 
questioned the presence of Bordetella bronchiseptica and some Mycoplasma species, 
as well as several viruses (canine respiratory coronavirus, canine parainfluenza, canine 
herpesvirus-1, etc.), including CAV-2 because the highest positivity rate was found for 
canine parainfluenza in their study population of dogs with CIRD. In a study conducted 
in Japan (MOCHIZUKI et al., 2008), although canine parainfluenza virus was the most 
frequently detected factor in dogs with CIRD that were taken to different animal hospitals, 
canine respiratory coronavirus, canine adenovirus-2, and canine distemper virus were 
also detected.
The Gene Bank has nucleotide entries for Brazil and China isolates of CAV-2 (Brazil; 
KU725674, China; GQ153311). It was determined that our isolates had 84.2%-99.7% 
nucleotide similarities with the reference strains (Table 2). The similarities among the 
strains in the study were 97.7%-98.9%. In the phylogenetic analyses (Fig. 2) of the strains 
isolated in our study and the reference strains obtained from the Gene Bank, Chinese 
isolates (GQ153311) appeared to have formed a subgroup with the strains isolated in this 
study. Other reference strains (USA, Canada, Brazil, and Italy) have been observed to 
form another subgroup, distinct from the subgroup including our viruses. Furthermore, 
some fixed substitutions found at 126, 136, 138, 172, 186, 216, 222, 227, and 254 could 
be the result of the differences in the CAV-2 subgroups. These differences could also 
account for the substitutions identified for positions 15, 97, 152, 187, 184, 221, and 250 
within the same subgroup, although this was a unique feature of the Turkish strains. The 
Turkish and Chinese strains of the 7 different amino acids were different from each other. 
This is a potentially interesting feature of the new subgroup. However, analyses of more 
and longer sequences are warranted to confirm this. In addition, another region needed to 
be amplified to obtain a phylogenetic tree confirming it. The gene regions (E1, E2, E3 and 
E4) of CAV-2 are responsible for efficient replication of the virus, viral gene expression 
and regulation of host-cell functions (MORRISON et al., 1997). Nine different amino 
acids have been identified on the molecular level (amino acid differences) between the 
China-Turkey isolates subgroup and the America-Europe subgroup strains. These amino 
acid differences suggest that the China-Turkey isolates group created a new subgroup. 
However, this must be analysed in different gene regions of the CAV-2 genome.
In conclusion, in this study, we explored CAV-2 nucleic acid detection and the 
relationship between CAV-2 and respiratory system infection in dogs belonging to two 
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shelters in Turkey. Additionally, our results revealed the possibility of a new subgroup of 
CAV within type 2 (CAV-2). The molecular characterization of the viruses from known 
dogs in different housing conditions (owned and kept inside a house, kept in front of 
the door, idling around, etc.) with varying vaccination history and age, would provide 
new information regarding the epidemiology of CAV-2 infections. Otherwise, knowledge 
of the possibility of different subgroups of CAV type 2 is also needed to enhance 
surveillance of circulating strains. Further, the study of other causative agents of CIRD 
in dogs detected with CAV-2 will also contribute to the knowledge on this subject and 
commercial vaccine use. 
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SAŽETAK
Adenovirusi su uzročnici odgovorni za dvije različite infekcije u pasa. Dok pseći adenovirus tipa 1 (CAV-
1) uzrokuje zarazni hepatitis (HCC), pseći adenovirus tipa 2 (CAV-2) odgovoran je za zarazni laringotraheitis 
(ILT). CAV-2, osobito u dišnom sustavu, uzrokuje infekciju sa smrtnim ishodom kod mladih životinja i onih 
koje žive u zajednicama. U javnim objektima kao što su skloništa, osim oportunističkih infekcija, učestao je i 
poremećaj koji se definira kao pseća zarazna bolest dišnih puteva (CIRD). Tijekom ovog istraživanja prikupljeno 
je 155 uzoraka krvi od pasa držanih u dva skloništa u kojima su pažljivo praćeni slučajevi infekcija dišnog 
sustava. Uzorci su testirani na CAV-2 primjenom lančane reakcije polimerazom (PCR), uz upotrebu početnica 
oblikovanih za gen CAV E3 (Early). Pozitivni su amplikoni podvrgnuti sekvenciranju DNA. CAV-2 nukleinske 
kiseline bile su prisutne u 2,5 % (4/155) istraženih uzoraka. Filogenetska analiza sekvencija amplikona otkrila je 
u lokalnim virusima 97,7 - 98,9 % sličnosti. Analize parcijalnih sekvencija gena CAV-2 E3 pokazale su da turski 
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i kineski sojevi imaju razlike u 9 aminokiselina. Te su razlike dodatno analizirane filogenetskim analizama i 
virus koji je smatran jedinstvenom skupinom, podijeljen je na dvije podskupine. Jedna su podskupina američko-
europski izolati, a druga se sastoji od turskih i kinskih izolata. Stoga se ovom podjelom mogu razlikovati 
najmanje dvije podskupine, označene kao Kina - Turska i Amerika - Europa. Pretpostavlja se da je ovo prvo 
istraživanje o mogućoj ulozi CAV-2 u infekcijama dišnog sustava pasa u Turskoj i kao takvo pruža nove 
informacije o CAV-2.
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